Sandoz Inc. 2023-03-09 Health safe CPSC
Health · CPSC · Recall #CPSC-23146
Aprepitant capsules and Lidocaine and Prilocaine cream Recall
Issued March 9, 2023 · Sandoz Inc. · 156,750 units affected
In March 2023, Sandoz Inc. recalled the Aprepitant capsules and Lidocaine and Prilocaine cream, a low-risk health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
What you should do
- 1 Stop using Aprepitant capsules and Lidocaine and Prilocaine cream right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Sandoz Inc. to arrange your new instructions. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (New Instructions): Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.
Recall details
- Brand
- Sandoz Inc.
- Category
- Health
- Recall date
- March 9, 2023
- Units affected
- 156,750
- Sold at
- Pharmacies nationwide as a prescribed medicine from October 2020 through January 2023. The prices of the medications varied based on health insurance terms and other factors.
- Recall number
- CPSC-23146
- Made in
- Slovenia (Aprepitant Capsules)
- Issuing agency
- CPSC
In context
- Sandoz Inc. has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- 156,750 units is enough to reach roughly 1 in every 836 US households.
- This is the 903rd Health recall we've logged in 2023.